These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24460887)

  • 1. Increased serum CXCL16 is highly correlated with blood lipids, urine protein and immune reaction in children with active nephrotic syndrome.
    Zhen J; Li Q; Zhu Y; Yao X; Wang L; Zhou A; Sun S
    Diagn Pathol; 2014 Jan; 9():23. PubMed ID: 24460887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the expression of HMGB-1, CXCL16, miRNA-30a, and TGF-β1 in primary nephritic syndrome patients and its significance.
    Wang WJ; Qu XQ; Yu XM; Lv W; Yu HY
    Genet Mol Res; 2015 Aug; 14(3):9841-8. PubMed ID: 26345917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
    Lv Y; Hou X; Ti Y; Bu P
    Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
    Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
    Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus.
    Zhao L; Wu F; Jin L; Lu T; Yang L; Pan X; Shao C; Li X; Lin Z
    PLoS One; 2014; 9(1):e87786. PubMed ID: 24489966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
    Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E
    Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
    Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.
    Mitsuoka H; Toyohara M; Kume N; Hayashida K; Jinnai T; Tanaka M; Kita T
    J Atheroscler Thromb; 2009 Oct; 16(5):586-93. PubMed ID: 19729872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
    PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL16 is a surrogate marker of inflammatory bowel disease.
    Lehrke M; Konrad A; Schachinger V; Tillack C; Seibold F; Stark R; Parhofer IG; Broedl UC
    Scand J Gastroenterol; 2008 Mar; 43(3):283-8. PubMed ID: 18938659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome.
    Guimarães FTL; Melo GEBA; Cordeiro TM; Feracin V; Vieira ER; Pereira WF; Pinheiro SVB; Miranda AS; Simões-E-Silva AC
    J Pediatr (Rio J); 2018; 94(5):546-553. PubMed ID: 28963877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
    Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
    Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
    Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
    Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
    Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement.
    le Blanc LM; van Lieshout AW; Adema GJ; van Riel PL; Verbeek MM; Radstake TR
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):145-8. PubMed ID: 16406320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble C-X-C chemokine ligand 16 levels are increased in gout patients.
    Gong Q; Wu F; Pan X; Yu J; Li Y; Lu T; Li X; Lin Z
    Clin Biochem; 2012 Nov; 45(16-17):1368-73. PubMed ID: 22627199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
    Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
    Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.